abstract |
The present invention provides polynucleotides and polypeptides which are diagnostic markers for prostate cancer. In addition, antibodies immunospecific for these markers are provided. Vectors, hosts cells and methods for producing these markers, as well as methods and tools for using these markers in detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating prostate cancer are also provided. |